Rujuan Xie

1.1k total citations
33 papers, 742 citations indexed

About

Rujuan Xie is a scholar working on Nephrology, Immunology and Surgery. According to data from OpenAlex, Rujuan Xie has authored 33 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 10 papers in Immunology and 6 papers in Surgery. Recurrent topics in Rujuan Xie's work include Renal Diseases and Glomerulopathies (8 papers), Chronic Kidney Disease and Diabetes (6 papers) and Platelet Disorders and Treatments (5 papers). Rujuan Xie is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Chronic Kidney Disease and Diabetes (6 papers) and Platelet Disorders and Treatments (5 papers). Rujuan Xie collaborates with scholars based in China and United States. Rujuan Xie's co-authors include Chengyuan Yu, Jialan Shi, Valerie A. Novakovic, Chengyue Wang, Jing Ma, Haijiao Jing, Xiaoming Wu, Ping Zhang, Xiao T. Chen and Lei Peng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Thrombosis and Haemostasis and Experimental Biology and Medicine.

In The Last Decade

Rujuan Xie

32 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rujuan Xie China 16 209 194 140 96 84 33 742
Ling Ji China 17 163 0.8× 258 1.3× 74 0.5× 54 0.6× 77 0.9× 51 989
Yunfeng Xia China 15 132 0.6× 225 1.2× 174 1.2× 77 0.8× 33 0.4× 37 643
Amber P. Sanchez United States 11 129 0.6× 106 0.5× 108 0.8× 74 0.8× 24 0.3× 20 583
Ichiro Koni Japan 16 86 0.4× 138 0.7× 130 0.9× 103 1.1× 107 1.3× 44 774
Manuel Alfredo Podestà Italy 19 218 1.0× 235 1.2× 538 3.8× 199 2.1× 77 0.9× 50 1.1k
Juan Cai China 18 185 0.9× 428 2.2× 209 1.5× 91 0.9× 37 0.4× 43 1.1k
Maria Rita Metelli Italy 18 111 0.5× 175 0.9× 235 1.7× 172 1.8× 67 0.8× 37 936
Jad Sfeir United States 13 192 0.9× 510 2.6× 66 0.5× 106 1.1× 83 1.0× 34 1.3k
Ning An China 17 187 0.9× 280 1.4× 132 0.9× 57 0.6× 115 1.4× 67 792
Chengyun Xu China 20 149 0.7× 472 2.4× 145 1.0× 93 1.0× 61 0.7× 62 958

Countries citing papers authored by Rujuan Xie

Since Specialization
Citations

This map shows the geographic impact of Rujuan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rujuan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rujuan Xie more than expected).

Fields of papers citing papers by Rujuan Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rujuan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rujuan Xie. The network helps show where Rujuan Xie may publish in the future.

Co-authorship network of co-authors of Rujuan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Rujuan Xie. A scholar is included among the top collaborators of Rujuan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rujuan Xie. Rujuan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chengyue, Chengyuan Yu, Haijiao Jing, et al.. (2022). Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Frontiers in Cellular and Infection Microbiology. 12. 861703–861703. 75 indexed citations
2.
Wang, Chengyue, Chengyuan Yu, Valerie A. Novakovic, Rujuan Xie, & Jialan Shi. (2022). Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury. Frontiers in Cell and Developmental Biology. 9. 784505–784505. 10 indexed citations
3.
Yu, Muxin, Tao Li, Baorong Li, et al.. (2020). Phosphatidylserine-exposing blood cells, microparticles and neutrophil extracellular traps increase procoagulant activity in patients with pancreatic cancer. Thrombosis Research. 188. 5–16. 33 indexed citations
4.
Liu, Yang, et al.. (2020). Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy. Medicina Clínica. 157(6). 267–273. 11 indexed citations
5.
Chen, Xiaojing, Chengyuan Yu, Haijiao Jing, et al.. (2020). COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.. American Journal of Translational Research. 12(12). 7640–7656. 8 indexed citations
6.
Xie, Rujuan, et al.. (2017). Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy. Medical Principles and Practice. 26(4). 375–380. 21 indexed citations
7.
Liu, Xiaogang, et al.. (2016). Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1–34 associated with the Ras-ERK signaling. Experimental Biology and Medicine. 241(16). 1745–1750. 4 indexed citations
8.
Wang, Yan, et al.. (2016). Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease. The American Journal of the Medical Sciences. 352(4). 348–353. 9 indexed citations
9.
Yu, Chengyuan, et al.. (2014). Clinical immunology<br>Relationship between hypoalbuminemia, hyperlipidemia and renal severity in patients with lupus nephritis: a prospective study. Central European Journal of Immunology. 39(2). 243–252. 22 indexed citations
10.
11.
12.
Sui, Meirong, Qingyuan Lin, Rujuan Xie, et al.. (2012). Simultaneous Positivity for Anti-DNA, Anti-Nucleosome and Anti-Histone Antibodies is a Marker for More Severe Lupus Nephritis. Journal of Clinical Immunology. 33(2). 378–387. 45 indexed citations
13.
Xie, Rujuan, et al.. (2012). Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy. Endocrine. 42(2). 329–334. 1 indexed citations
14.
Li, Ping, Linlin Ma, Rujuan Xie, et al.. (2012). Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure. Acta Pharmacologica Sinica. 33(5). 644–651. 26 indexed citations
15.
Gao, Chunyan, Rui Xie, Fangfang Shi, et al.. (2012). Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thrombosis and Haemostasis. 107(4). 681–689. 72 indexed citations
16.
Zhang, Ping, et al.. (2011). Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease. Journal of Clinical Immunology. 32(3). 587–594. 57 indexed citations
17.
Zhang, Ping, Rujuan Xie, Mei Wang, et al.. (2011). The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2. International Immunopharmacology. 11(10). 1599–1605. 33 indexed citations
18.
19.
Ling, Hong, et al.. (2005). [The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].. PubMed. 85(29). 2076–80. 5 indexed citations
20.
Ling, Hong, et al.. (2005). Interleukin-10 genotype protects end stage renal disease patients from microinflammation and arteriosclerosis.. PubMed. 118(18). 1549–51. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Ji Breakdown of academic impact, for papers by Yunfeng Xia Breakdown of academic impact, for papers by Amber P. Sanchez Breakdown of academic impact, for papers by Ichiro Koni Breakdown of academic impact, for papers by Manuel Alfredo Podestà Breakdown of academic impact, for papers by Juan Cai Breakdown of academic impact, for papers by Maria Rita Metelli Breakdown of academic impact, for papers by Jad Sfeir Breakdown of academic impact, for papers by Ning An Breakdown of academic impact, for papers by Chengyun Xu
Rankless by CCL
2026